World Immunotherapy Council’s 4th Young Investigator Symposium

World Immunotherapy Council's 4th Young Investigator Symposium

Additional registration is required

Wednesday, Nov. 10, 2021*
7:30 a.m.–1 p.m. EST

*Date and times subject to change. 

Program Purpose

The Society for Immunotherapy of Cancer (SITC) and the World Immunotherapy Council (WIC) are dedicated to advancing cancer immunotherapy and, likewise, the future leaders of the field. This program will provide the opportunity for young scientists and future leaders from throughout the world to interact, fulfilling the World Immunotherapy Council’s mission to facilitate rapid development and global dissemination of cancer immunotherapies through scientific exchange.

The young investigators, each chosen for exemplary work in the field of cancer immunotherapy, will contribute insight and perspectives into present and future issues, challenges, and improvements as cancer immunotherapy is integrated into mainstream cancer treatment. This program and its participants will ultimately highlight worldwide initiatives in cancer immunotherapy and facilitate scientific exchange and networking between today’s and tomorrow’s leaders. Additionally, this forum will provide a unique opportunity to showcase the world’s young, talented scientists and provide an opportunity for knowledge exchange and networking for these selected representatives.

Program Organizers

  • Bernard A. Fox, PhD – Earle A. Chiles Research Institute, Providence Cancer Institute
  • Tanja de Gruijl, PhD – Amsterdam University Medical Centers
  • Barbara Seliger, MD, PhD – Institute of Medical Immunology

Target Audience

The target audience for this program consists of individuals from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals who wish to learn more about the future of cancer immunotherapy research across the globe.

SITC's World Immunotherapy Council's 4th Young Investigator Symposium is supported in part by grants from Bristol Myers Squibb and Pfizer, Inc.

Program Schedule

To be announced soon